The corn smut ('Huitlacoche') as a new platform for oral vaccines

PLoS ONE

Volumn 10, Issue 7, 2015, Pages

  Juárez Montiel, Margarita ^a   Romero Maldonado, Andrea ^b   Monreal Escalante, Elizabeth ^b   Becerra Flora, Alicia ^a   Korban, Schuyler S ^c   Rosales Mendoza, Sergio ^b   Jiménez Bremont, Juan Francisco ^a  

^a INSTITUTO POTOSINO DE INVESTIGACIÓN CIENTÍFICA Y TECNOLÓGICA   (Mexico)

^b UNIVERSIDAD AUTÓNOMA DE SAN LUIS POTOSÍ   (Mexico)

^c UNIVERSITY OF MASSACHUSETTS BOSTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLERA TOXIN B SUBUNIT; CHOLERA TOXIN B SUBUNIT RECOMBINANT PROTEIN; RECOMBINANT PROTEIN; SUBUNIT VACCINE; UNCLASSIFIED DRUG; CHOLERA TOXIN; CHOLERA VACCINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHOLERA; CONTROLLED STUDY; CORN SMUT; COST EFFECTIVENESS ANALYSIS; CTB GENE; DRUG EFFICACY; DRUG SAFETY; DRY WEIGHT; FEASIBILITY STUDY; FEMALE; FUNGAL GENE; FUNGAL STRAIN; GENETIC ENGINEERING; HUMORAL IMMUNITY; IMMUNOGENICITY; MOUSE; NONHUMAN; PLANT DISEASE; PROTEIN EXPRESSION; TRANSGENIC ORGANISM; USTILAGO MAYDIS; VACCINATION; VACCINE PRODUCTION; ANIMAL; BIOSYNTHESIS; IMMUNIZATION; IMMUNOLOGY; MAIZE; MOLECULAR FARMING;

ANIMALS; CHOLERA; CHOLERA TOXIN; CHOLERA VACCINES; IMMUNIZATION; MICE; MOLECULAR FARMING; ZEA MAYS;

EID: 84941710743     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0133535     Document Type: Article

References (50)

1. Juárez-Montiel M, Ruiloba de León S, Chávez-Camarillo G, Hernández-Rodríguez C, Villa-Tanaca L. Huitlacoche (corn smut), caused by the phytopathogenic fungus Ustilago maydis, as a functional food. Rev Iberoam Micol. 2011; 28: 69-73. doi: 10.1016/j.riam.2011.01.001 PMID: 21352944
2. Ruíz-Herrera J, Martínez-Espinoza AD. The fungus Ustilago maydis: from the aztec cuisine to the research laboratory. Int Microbiol. 1998; 1: 149-58. PMID: 10943353
3. Valdez-Morales M, Barry K, Fahey GC Jr, Domínguez J, González de Mejia E, Valverde ME, et al. Effect of maize genotype, developmental stage, and cooking process on the nutraceutical potential of huitlacoche (Ustilago maydis). Food Chem. 2010; 119: 689-697.
4. Bölker M, Basse CW, Schirawski J. Ustilago maydis secondary metabolism-From genomics to biochemistry. Fungal Genet Biol. 2008; 45:S88-S93. doi: 10.1016/j.fgb.2008.05.007 PMID: 18585066
5. Banuett F. Genetics of Ustilago maydis, a fungal pathogen that induces tumors in maize. Annu Rev Genet. 1995; 29: 179-208. PMID: 8825473
6. Banuett F, Herskowitz I. Discrete developmental stages during teliospore formation in the corn smut fungus, Ustilago maydis. Development. 1996; 122: 2965-2976. PMID: 8898211
7. Spellig T, Bölker M, Lottspeich F, Frnak RW, Kahmann R. Pheromones trigger filamentous growth in Ustilago maydis. EMBO J. 1994; 13: 1620-1627. PMID: 8157001
8. Gillenssen B, Bergemann J, Sandmann C, Schroeer B, Bolker M, Kahmann R.A two-component regulatory system for self/non-self recognition in Ustilago maydis. Cell. 1992; 68: 647-657. PMID: 1739973
9. Brachmann A, König J, Julius C, Feldbrügge M. A reverse genetic approach for generating gene replacement mutants in Ustilago maydis. Mol Genet Genomics. 2004; 272: 216-226. PMID: 15316769
10. Kämper J, Kahmann R, Bölker M, Ma LJ, Brefort T, Saville BJ, et al. Insights from the genome of the biotrophic fungal plant pathogen Ustilago maydis. Nature. 2006; 444: 97-101. PMID: 17080091
11. Terfrüchte M, Joehnk B, Fajardo-Somera R, Braus GH, Riquelme M, Schipper K, et al. Establishing a versatile golden gate cloning system for genetic engineering in fungi. Fungal Genet Biol. 2014; 62: 1-10. doi: 10.1016/j.fgb.2013.10.012 PMID: 24211735
12. Feldbrügge M, Kellner R, Schipper K. The biotechnological use and potential of plant pathogenic smut fungi. Appl Microbiol Biotechnol. 2013; 97: 3253-3265. doi: 10.1007/s00253-013-4777-1 PMID: 23455565
13. Rosales-Mendoza S, Salazar-González JA. Immunological aspects of using plant cells as delivery vehicles for oral vaccines. Expert Rev Vaccines. 2014; 13: 737-749. doi: 10.1586/14760584.2014. 913483 PMID: 24766405
14. Shin MK, Yoo HS. Animal vaccines based on orally presented yeast recombinants. Vaccine. 2013; 31: 4287-4292. doi: 10.1016/j.vaccine.2013.07.029 PMID: 23891501
15. Wilkhu J, McNeil SE, Kirby DJ, Perrie Y. Formulation design considerations for oral vaccines. Ther Deliv. 2011; 2: 1141-1164. PMID: 22833911
16. Giddings G, Allison G, Brooks D, Carter A. Transgenic plants as factories for biopharmaceuticals. Nat Biotechnol. 2000; 18: 1151-1155. PMID: 11062432
17. Nevalainen H, Peterson R. Making recombinant proteins in filamentous fungi- are we expecting too much?. Front Microbiol. 2014; 5: 75. doi: 10.3389/fmicb.2014.00075. eCollection. PMID: 24578701
18. Langridge W, Dénes B, Fodor I. Cholera toxin B subunit modulation of mucosal vaccines for infectious and autoimmune diseases. Curr Opin Investig Drugs. 2010; 11: 919-928. PMID: 20721834
19. George-Chandy A, Eriksson K, Lebens M, Nordström I, Schön E, Holmgren J. Cholera toxin B subunit as a carrier molecule promotes antigen presentation and increases CD40 and CD86 expression on antigen-presenting cells. Infect Immun. 2001; 69: 5716-5725. PMID: 11500448
20. Sun JB, Czerkinsky C, Holmgren J. Mucosally induced immunological tolerance, regulatory T cells and the adjuvant effect by cholera toxin B subunit. Scand J Immunol. 2010; 71: 1-11. doi: 10.1111/j.1365- 3083.2009.02321.x PMID: 20017804
21. Merritt EA, Sarfaty S, van den Akker F, L'Hoir C, Martial JA, Hol WG. Crystal structure of cholera toxin B-pentamer bound to receptor GM1 pentasaccharide. Protein Sci. 1994; 3: 166-175. PMID: 8003954
22. Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, et al. Current protocols in molecular biology. New York: Greene Publishing Associates and Wiley-Interscience; 1987.
23. Schmitt ME, Brown TA, Trumpower BL. A rapid and simple method for preparation of RNA from Saccharomyces cerevisiae. Nucleic Acids Res. 1990; 18: 3091. PMID: 2190191
24. Rodríguez-Kessler M, Baeza-Monta?ez L, García-Pedrajas MD, Tapia-Moreno A, Gold S, Jiménez- Bremont JF, et al. Isolation of UmRrm75, a gene involved in dimorphism and virulence of Ustilago maydis. Microbiol Res. 2012; 167: 270-282. doi: 10.1016/j.micres.2011.10.007 PMID: 22154329
25. Hernández-Rodríguez AA, Ortega-Amaro MA, Delgado-Sánchez P, Salinas J, Jiménez-Bremont JF. AtGRDP1 gene encoding a glycine-rich domain protein is involved in germination and responds to ABA signalling. Plant Mol Biol Rep. 2014; 32: 1187-1202. doi: 10.1007/s11105-014-0714-4
26. Holliday R. Ustilago maydis. In: King RC, editor. Handbook of genetics, vol. 1. New York: Plenum; 1974. pp. 575-595.
27. Franklin S, Ngo B, Efuet E, Mayfield SP. Development of a GFP reporter gene for Chlamydomonas reinhardtii chloroplast. Plant J. 2002; 30:733-744. PMID: 12061904
28. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin Phenol Reagent. J Biol Chem. 1951; 193: 265-275. PMID: 14907713
29. Chikwamba RL, Cunnick J, Hathaway D, McMurray J, Mason H, Wang K. Functional antigen in a practical crop: LT-B producing maize protects mice against Escherichia coli heat labile enterotoxin (LT) and cholera toxin (CT). Transgenic Res. 2002; 11: 479-493. PMID: 12437079
30. Rosales-Mendoza S, Soria-Guerra RE, López-Revilla R, Moreno-Fierros L, Alpuche-Solís AG. Ingestion of transgenic carrots expressing the Escherichia coli heat-labile enterotoxin B subunit protects mice against cholera toxin challenge. Plant Cell Rep. 2008; 27: 79-84. PMID: 17874110
31. Richardson SH, Giles JC, Kruger KS. Sealed adult mice: new model for enterotoxin evaluation. Infect Immun. 1984; 43: 482-486. PMID: 6363287
32. Spellig T, Bottin A, Kahmann R. Green fluorescent protein (GFP) as new vital marker in the phytopathogenic fungus Ustilago maydis. Mol Gen Genet. 1996; 252: 503-509. PMID: 8914511
33. Soria-Guerra RE, Moreno-Fierros L, Rosales-Mendoza S. Two decades of plant-based candidate vaccines: a review of the chimeric protein approaches. Plant Cell Rep. 2011; 30: 1367-1382. doi: 10.1007/ s00299-011-1065-3 PMID: 21505834
34. Rosales-Mendoza S, Paz-Maldonado LM, Soria-Guerra RE. Chlamydomonas reinhardtii as a viable platform for the production of recombinant proteins: current status and perspectives. Plant Cell Rep. 2012; 31: 479-494. doi: 10.1007/s00299-011-1186-8 PMID: 22080228
35. Hamorsky KT, Kouokam JC, Bennett LJ, Baldauf KJ, Kajiura H, Fujiyama K. Rapid and scalable plantbased production of a cholera toxin B subunit variant to aid in mass vaccination against Cholera outbreaks. PLoS Negl Trop Dis. 2013; 7: e2046. doi: 10.1371/journal.pntd.0002046 PMID: 23505583
36. Harakuni T, Sugawa H, Komesu A, Tadano M, Arakawa T. Heteropentameric cholera toxin B subunit chimeric molecules genetically fused to a vaccine antigen induce systemic and mucosal immune responses: a potential new strategy to target recombinant vaccine antigens to mucosal immune systems. Infec Immun. 2005; 73: 5654-5665.
37. Payero JO, Melvin SR, Irmak S, Tarkalson D. Yield response of corn to deficit irrigation in a semiarid climate. Agric Water Manage. 2006; 84: 101-112.
38. Twyman RM, Stoger E, Schillberg S, Christou P, Fischer R. Molecular farming in plants: host systems and expression technology. Trends Biotechnol. 2003; 21: 570-578. PMID: 14624867
39. Ward OP. Production of recombinant proteins by filamentous fungi. Biotechnol Adv. 2012; 30: 1119-1139. doi: 10.1016/j.biotechadv.2011.09.012 PMID: 21968147
40. Matsumoto Y, Suzuki S, Nozoye T, Yamakawa T, Takashima Y, Arakawa T, et al. Oral immunogenicity and protective efficacy in mice of transgenic rice plants producing a vaccine candidate antigen (As16) of Ascaris suum fused with cholera toxin B subunit. Transgenic Res. 2009; 18: 185-192. doi: 10.1007/ s11248-008-9205-4 PMID: 18763047
41. Nozoye T, Takaiwa F, Tsuji N, Yamakawa T, Arakawa T, Hayashi Y, et al. Production of Ascaris suum As14 protein and its fusion protein with cholera toxin B subunit in rice seeds. J Vet Med Sci. 2009; 71: 995-1000. PMID: 19652493
42. Karaman S, Cunnick J, Wang K. Expression of the cholera toxin B subunit (CT-B) in maize seeds and a combined mucosal treatment against cholera and traveler's diarrhea. Plant Cell Rep. 2012; 31: 527-537. doi: 10.1007/s00299-011-1146-3 PMID: 21938449
43. Daniell H, Singh ND, Mason H, Streatfield SJ. Plant-made vaccine antigens and biopharmaceuticals. Trends Plant Sci. 2009; 14: 669-679. doi: 10.1016/j.tplants.2009.09.009 PMID: 19836291
44. Miyata T, Harakuni T, Taira T, Matsuzaki G, Arakawa T. Merozoite surface protein-1 of Plasmodium yoelii fused via an oligosaccharide moiety of cholera toxin B subunit glycoprotein expressed in yeast induced protective immunity against lethal malaria infection in mice. Vaccine. 2012; 30: 948-958. doi: 10.1016/j.vaccine.2011.11.059 PMID: 22119928
45. Wang LX, Lomino JV. Emerging technologies for making glycan-defined glycoproteins. ACS Chem Biol. 2012; 7: 110-122. doi: 10.1021/cb200429n PMID: 22141574
46. Bosch D, Schots A. Plant glycans: friend or foe in vaccine development?. Expert Rev Vaccines. 2010; 9: 835-842. doi: 10.1586/erv.10.83 PMID: 20673008
47. Stock J, Sarkari P, Kreibich S, Brefort T, Feldbrügge M, Schipper K. Applaying unconventional secretion of the endochitinase CTS1 to export heterologous proteins in Ustilago maydis. J Biotechnol. 2012; 161: 80-91. doi: 10.1016/j.jbiotec.2012.03.004 PMID: 22446315
48. Fernández-Alvarez A, Elías-Villalobos A, Ibeas JI. Protein glycosylation in the phytopathogen Ustilago maydis: From core oligossacharide synthesis to the ER glycoprotein quality control system, a genomic analysis. Fungal Genet Biol. 2010; 47: 727-735. doi: 10.1016/j.fgb.2010.06.004 PMID: 20554055
49. Maskery B, DeRoeck D, Levin A, Kim YE, Wierzba TF, Clemens JD. Strategy, demand, management, and costs of an international cholera vaccine stockpile. J Infect Dis. 2013; 208 Suppl 1: S15-22. doi: 10.1093/infdis/jit233 PMID: 24101640
50. Basset C, Thiam F, Martino CD, Holton J, Clements JD, Kohli E. Cholera-like enterotoxins and Regulatory T cells. Toxins (Basel). 2010; 2: 1774-1795. doi: 10.3390/toxins2071774